合成2D乳腺摄影与标准2D数字乳腺摄影的诊断准确性系统评价与Meta分析
该系统评价与Meta分析纳入13项研究、共201304例患者,比较合成2D乳腺摄影(SM)与标准2D数字乳腺摄影(DM)及各自联合数字乳腺断层摄影(DBT)对乳腺癌检出的诊断准确性。结果显示SM组与DM组、SM联合DBT组与DM联合DBT组的诊断准确性相当,Meta回归未发现SM与DM组间准确性有显著差异(p=.25-.77)。结论支持以SM替代标准DM进行乳腺摄影成像,可能降低总体辐射暴露。
要点
- SM联合DBT诊断准确性(敏感度85%、特异度93%)与DM联合DBT(敏感度84%、特异度91%)相当。
- SM单独使用与DM单独使用诊断准确性无显著差异(Meta回归p=.25-.77)。
- SM替代标准DM可降低辐射剂量而不牺牲诊断准确性。
诊断标准与关键数值
- SM组(6项研究,20728例患者,724例乳腺癌):敏感度75%(95%CI 67-82%),特异度92%(95%CI 85-96%)。
- DM组(9项研究,52082例患者,2249例乳腺癌):敏感度73%(95%CI 65-80%),特异度88%(95%CI 77-94%)。
- SM联合DBT组(10项研究,64224例患者,2149例乳腺癌):敏感度85%(95%CI 80-89%),特异度93%(95%CI 86-96%)。
- DM联合DBT组(9项研究,64270例患者,2130例乳腺癌):敏感度84%(95%CI 80-88%),特异度91%(95%CI 83-95%)。
临床应用与阅片要点
- 研究结果支持以SM替代标准DM进行乳腺摄影成像,可能降低总体辐射暴露。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. The use of synthetic 2D mammography (SM) with digital breast tomosynthesis (DBT) in place of standard 2D digital mammography (DM) may reduce radiation dose without sacrificing accuracy. OBJECTIVE. The purpose of our study was to compare the diagnostic accuracy of SM, DM, SM with DBT, and DM with DBT for breast cancer detection. EVIDENCE ACQUISITION. A search of MEDLINE, Embase, and Cochrane databases was performed for relevant articles published up to September 11, 2019. Studies included compared the diagnostic accuracy of SM versus DM and SM plus DBT versus DM plus DBT for breast cancer detection. Relevant study data metrics and risk of bias were assessed. A bivariate random-effects meta-analysis and meta-regression were performed to assess diagnostic accuracy (PROSPERO CRD42020150737). EVIDENCE SYNTHESIS. Thirteen studies reporting on 201,304 patients (7252 patients with breast cancer) were included. The SM group (six studies: 20,728 patients, 724 with breast cancer) had 75% sensitivity (95% CI, 67-82%) and 92% specificity (95% CI, 85-96%). The DM group (nine studies: 52,082 patients, 2249 patients with breast cancer) had 73% sensitivity (95% CI, 65-80%) and 88% specificity (95% CI, 77-94%). The SM plus DBT group (10 studies, 64,224 patients, 2149 with breast cancer) had 85% sensitivity (95% CI, 80-89%) and 93% specificity (95% CI, 86-96%). The DM plus DBT group (nine studies, 64,270 patients, 2130 with breast cancer) had 84% sensitivity (95% CI, 80-88%) and 91% specificity (95% CI, 83-95%). Meta-regression models did not reveal significant differences in accuracy between the SM and DM groups (p = .25-.77). CONCLUSION. SM and SM plus DBT showed comparable diagnostic accuracy to DM and DM plus DBT, respectively. CLINICAL IMPACT. The findings support the implementation of SM in place of standard DM for mammographic imaging of the breasts. This may lead to an overall reduction in radiation exposure.
引用
- Abdullah P, Alabousi M, Ramadan S, et al. Synthetic 2D Mammography Versus Standard 2D Digital Mammography: A Diagnostic Test Accuracy Systematic Review and Meta-Analysis. AJR Am J Roentgenol. 2020. PMID: 32966115. doi:10.2214/AJR.20.24204
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。